
FDA Cancels Cipla’s Drug Licence at Pune Warehouse
The story in brief
The FDA canceled Cipla Pharma & Life Sciences Ltd’s wholesale drug licence at Wadki in Pune due to alleged regulatory and storage irregularities. The cancellation followed Bombay High Court directions and affects the operation of the C&F warehouse, impacting drug distribution and storage protocols. Cipla is reviewing the order and evaluating further options.